118 related articles for article (PubMed ID: 15857613)
21. Characterization of N-(1-Acetyl-2,3-dihydro-1H-indol-6-yl)-3-(3-cyano-phenyl)-N-[1-(2-cyclopentyl-ethyl)-piperidin-4yl]acrylamide (JNJ-5207787), a small molecule antagonist of the neuropeptide Y Y2 receptor.
Bonaventure P; Nepomuceno D; Mazur C; Lord B; Rudolph DA; Jablonowski JA; Carruthers NI; Lovenberg TW
J Pharmacol Exp Ther; 2004 Mar; 308(3):1130-7. PubMed ID: 14617685
[TBL] [Abstract][Full Text] [Related]
22. Functional expression of neuropeptide Y receptors in human neuroblastoma cells.
Li AJ; Ritter S
Regul Pept; 2005 Jul; 129(1-3):119-24. PubMed ID: 15927706
[TBL] [Abstract][Full Text] [Related]
23. Pharmacological characterization and appetite suppressive properties of BMS-193885, a novel and selective neuropeptide Y(1) receptor antagonist.
Antal-Zimanyi I; Bruce MA; Leboulluec KL; Iben LG; Mattson GK; McGovern RT; Hogan JB; Leahy CL; Flowers SC; Stanley JA; Ortiz AA; Poindexter GS
Eur J Pharmacol; 2008 Aug; 590(1-3):224-32. PubMed ID: 18573246
[TBL] [Abstract][Full Text] [Related]
24. Cloning and functional expression of the hNPY Y5 receptor in human endometrial cancer (HEC-1B) cells.
Moser C; Bernhardt G; Michel J; Schwarz H; Buschauer A
Can J Physiol Pharmacol; 2000 Feb; 78(2):134-42. PubMed ID: 10737676
[TBL] [Abstract][Full Text] [Related]
25. Cross-talk between G(s)- and G(q)-coupled pathways in regulation of interleukin-4 by A(2B) adenosine receptors in human mast cells.
Ryzhov S; Goldstein AE; Biaggioni I; Feoktistov I
Mol Pharmacol; 2006 Aug; 70(2):727-35. PubMed ID: 16707627
[TBL] [Abstract][Full Text] [Related]
26. Coexpression with potassium channel subunits used to clone the Y2 receptor for neuropeptide Y.
Rimland JM; Seward EP; Humbert Y; Ratti E; Trist DG; North RA
Mol Pharmacol; 1996 Mar; 49(3):387-90. PubMed ID: 8643076
[TBL] [Abstract][Full Text] [Related]
27. Phenoxybenzamine and benextramine, but not 4-diphenylacetoxy-N-[2-chloroethyl]piperidine hydrochloride, display irreversible noncompetitive antagonism at G protein-coupled receptors.
Bodenstein J; Venter DP; Brink CB
J Pharmacol Exp Ther; 2005 Aug; 314(2):891-905. PubMed ID: 15857948
[TBL] [Abstract][Full Text] [Related]
28. Complex plastic changes in the neuropeptide Y system during ethanol intoxication and withdrawal in the rat brain.
Olling JD; Ulrichsen J; Christensen DZ; Woldbye DP
J Neurosci Res; 2009 Aug; 87(10):2386-97. PubMed ID: 19267419
[TBL] [Abstract][Full Text] [Related]
29. Dynorphin binds to neuropeptide Y and peptide YY receptors in human neuroblastoma cell lines.
Miura M; Inui A; Sano K; Ueno N; Teranishi A; Hirosue Y; Nakajima M; Okita M; Togami J; Koshiya K
Am J Physiol; 1994 Nov; 267(5 Pt 1):E702-9. PubMed ID: 7977721
[TBL] [Abstract][Full Text] [Related]
30. Neuropeptide Y does not reset the circadian clock in NPY Y2-/- mice.
Soscia SJ; Harrington ME
Neurosci Lett; 2005 Jan; 373(3):175-8. PubMed ID: 15619538
[TBL] [Abstract][Full Text] [Related]
31. Coupling of the human Y2 receptor for neuropeptide Y and peptide YY to guanine nucleotide inhibitory proteins in permeabilized SMS-KAN cells.
Freitag C; Svendsen AB; Feldthus N; Løssl K; Sheikh SP
J Neurochem; 1995 Feb; 64(2):643-50. PubMed ID: 7830057
[TBL] [Abstract][Full Text] [Related]
32. Neuropeptide Y regulates recurrent mossy fiber synaptic transmission less effectively in mice than in rats: Correlation with Y2 receptor plasticity.
Tu B; Jiao Y; Herzog H; Nadler JV
Neuroscience; 2006 Dec; 143(4):1085-94. PubMed ID: 17027162
[TBL] [Abstract][Full Text] [Related]
33. Activation of neuropeptide Y Y1 receptors inhibits glutamate release through reduction of voltage-dependent Ca2+ entry in the rat cerebral cortex nerve terminals: suppression of this inhibitory effect by the protein kinase C-dependent facilitatory pathway.
Wang SJ
Neuroscience; 2005; 134(3):987-1000. PubMed ID: 16026936
[TBL] [Abstract][Full Text] [Related]
34. Evidence for the functional expression and pharmacological characterization of adenine receptors in native cells and tissues.
Gorzalka S; Vittori S; Volpini R; Cristalli G; von Kügelgen I; Müller CE
Mol Pharmacol; 2005 Mar; 67(3):955-64. PubMed ID: 15604413
[TBL] [Abstract][Full Text] [Related]
35. The anti-epileptic actions of neuropeptide Y in the hippocampus are mediated by Y and not Y receptors.
El Bahh B; Balosso S; Hamilton T; Herzog H; Beck-Sickinger AG; Sperk G; Gehlert DR; Vezzani A; Colmers WF
Eur J Neurosci; 2005 Sep; 22(6):1417-30. PubMed ID: 16190896
[TBL] [Abstract][Full Text] [Related]
36. Identification of MrgX2 as a human G-protein-coupled receptor for proadrenomedullin N-terminal peptides.
Kamohara M; Matsuo A; Takasaki J; Kohda M; Matsumoto M; Matsumoto S; Soga T; Hiyama H; Kobori M; Katou M
Biochem Biophys Res Commun; 2005 May; 330(4):1146-52. PubMed ID: 15823563
[TBL] [Abstract][Full Text] [Related]
37. Neuropeptide Y inhibits [Ca2+]i changes in rat retinal neurons through NPY Y1, Y4, and Y5 receptors.
Alvaro AR; Rosmaninho-Salgado J; Ambrósio AF; Cavadas C
J Neurochem; 2009 Jun; 109(5):1508-15. PubMed ID: 19344373
[TBL] [Abstract][Full Text] [Related]
38. Staurosporine differentiation of NPFF2 receptor-transfected SH-SY5Y neuroblastoma cells induces selectivity of NPFF activity towards opioid receptors.
Mollereau C; Zajac JM; Roumy M
Peptides; 2007 May; 28(5):1125-8. PubMed ID: 17418451
[TBL] [Abstract][Full Text] [Related]
39. Neuropeptide Y induces gonadotropin-releasing hormone gene expression directly and through conditioned medium from mHypoE-38 NPY neurons.
Dhillon SS; Gingerich S; Belsham DD
Regul Pept; 2009 Aug; 156(1-3):96-103. PubMed ID: 19371763
[TBL] [Abstract][Full Text] [Related]
40. Do heterotrimeric G proteins redistribute upon G protein-coupled receptor stimulation in platelets?
Kahner BN; Quinton TM; Langan S; Kunapuli SP
Platelets; 2006 Sep; 17(6):397-404. PubMed ID: 16973501
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
